It has been shown that ciRS-7/CDR1as is downregulated in the brains of AD patients [177,199] and affects the expression of UBE2A, which is crucial for clearance of Aβ via proteolysis in AD [177]. This evidence concerns the gene UBE2A and Alzheimer disease.